These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34044801)

  • 1. Robust expression of LINE-1 retrotransposon encoded proteins in oral squamous cell carcinoma.
    Mukherjee K; Sur D; Singh A; Rai S; Das N; Sekar R; Narindi S; Dhingra VK; Jat B; Balraam KVV; Agarwal SP; Mandal PK
    BMC Cancer; 2021 May; 21(1):628. PubMed ID: 34044801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINE-1 retrotransposon encoded ORF1p expression and promoter methylation in oral squamous cell carcinoma: a pilot study.
    Budania S; Sur D; Nangal J; Pilli S; Mukherjee K; Biswas M; Prasad R; Saxena S; Mandal PK
    Cancer Genet; 2020 Jun; 244():21-29. PubMed ID: 32088612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human LINE-1 retrotransposition requires a metastable coiled coil and a positively charged N-terminus in L1ORF1p.
    Khazina E; Weichenrieder O
    Elife; 2018 Mar; 7():. PubMed ID: 29565245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L1-ORF1p, a Smad4 interaction protein, promotes proliferation of HepG2 cells and tumorigenesis in mice.
    Zhu Y; Feng F; Yu J; Song B; Hu M; Gao X; Wang Y; Zhang Q
    DNA Cell Biol; 2013 Sep; 32(9):531-40. PubMed ID: 23863096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of L1-Ribonucleoprotein Particles (L1-RNPs) from Cultured Human Cells.
    Mandal PK; Kazazian HH
    Methods Mol Biol; 2016; 1400():299-310. PubMed ID: 26895061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-610 functions as a tumor suppressor in oral squamous cell carcinoma by directly targeting AGK.
    Yao LX; Liu J; Xu L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):187-197. PubMed ID: 30657560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00961 suppresses cell proliferation and induces cell apoptosis in oral squamous cell carcinoma.
    Pan LN; Sun YR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3358-3365. PubMed ID: 31081090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression.
    Xu D; Gu M; Liu HL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):641-648. PubMed ID: 30720172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 11. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
    Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
    Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-373 promotes proliferation and metastasis of oral squamous cell carcinoma by targeting SPOP.
    Zhang XJ; Jin Y; Song JL; Deng F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5270-5276. PubMed ID: 31298378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of RNase 7 in the malignant potential of oral squamous cell carcinoma cells.
    Neopane P; Kurashige Y; Yoshida K; Uehara O; Paudel D; Morikawa T; Sato J; Saitoh M; Abiko Y
    Oncol Rep; 2020 Sep; 44(3):1216-1223. PubMed ID: 32705284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
    Ji L; Zhu ZN; He CJ; Shen X
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly active synthetic mammalian retrotransposon.
    Han JS; Boeke JD
    Nature; 2004 May; 429(6989):314-8. PubMed ID: 15152256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition.
    Dai L; Huang Q; Boeke JD
    BMC Biochem; 2011 May; 12():18. PubMed ID: 21545744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.
    Inoue K; Hatano K; Hanamatsu Y; Saigo C; Kito Y; Bunai K; Shibata T; Takeuchi T
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):851-859. PubMed ID: 30635792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Scanning Mutagenesis of Human Retrotransposon LINE-1 Identifies Motifs Essential for Function.
    Adney EM; Ochmann MT; Sil S; Truong DM; Mita P; Wang X; Kahler DJ; Fenyö D; Holt LJ; Boeke JD
    Genetics; 2019 Dec; 213(4):1401-1414. PubMed ID: 31666291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
    Liu Y; Li R; Ren G
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.